Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-bmra
/
Biomerica Inc
BMRA
Add to Watchlist
1.750
USD
-0.020
-1.13%
Close 07/02, 13:00(ET)
Quotes delayed by 15 min
USD
0.000
After-hours (ET)
5.16M
Market Cap
Loss
P/E TTM
Biomerica Inc
1.750
-0.020
-1.13%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Revenue Breakdown
Currency: USD
Updated: Mon, Apr 6
Currency: USD
Updated: Mon, Apr 6
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
By Business
USD
Name
Revenue
Proportion
Clinical Lab
676.00K
55.87%
OTC
361.00K
29.83%
Contract Manufacturing
172.00K
14.21%
Physicians’ Office
1.00K
0.08%
By Region
USD
Name
Revenue
Proportion
United States
443.00K
36.61%
Asia
358.00K
29.59%
Europe
262.00K
21.65%
Middle East
137.00K
11.32%
South America
10.00K
0.83%
By Business
By Region
By Business
USD
Name
Revenue
Proportion
Clinical Lab
676.00K
55.87%
OTC
361.00K
29.83%
Contract Manufacturing
172.00K
14.21%
Physicians’ Office
1.00K
0.08%